Concert Pharmaceuticals, Inc.
(NASDAQ GM: CNCE)
Rigrodsky Law, P.A. is investigating Concert Pharmaceuticals, Inc. (“Concert”) regarding possible breaches of fiduciary duties and other violations of law related to Concert’s agreement to be acquired by Sun Pharmaceutical Industries Limited.